Athletic Fundraiser Breaks Another Record in Support of Cancer Research and Care BOSTON–(BUSINESS WIRE)–The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber Cancer Institute. Since its founding in 1980, the PMC has raised a total of … [Read more…]
Serenity clinics offer accessible TMS treatment for mental health. COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, is setting the standard for TMS therapy in Colorado Springs. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners provide full-spectrum mental … [Read more…]
Patients nationwide can access faster, convenient TMS treatment. COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced that its patients now have immediate access to the FDA-cleared accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) protocol from BrainsWay for … [Read more…]
LYON, France–(BUSINESS WIRE)–Regulatory News: POXEL SA (Euronext : POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the appointment of Yves Decadt as a member of its Board of Directors. Following the governance changes implemented … [Read more…]
MOBILE, Ala.–(BUSINESS WIRE)–TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced that it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. The Company will host a conference … [Read more…]
Ninja Swirl™ is featured in the Season 9 reunion episode as SharkNinja showcases its fast, culture-driven marketing approach NEEDHAM, Mass.–(BUSINESS WIRE)–SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced a partnership with Netflix’s Love Is Blind. The partnership is a fun play on one of the season’s most viral moments featuring … [Read more…]
CAL101 is a first-in-class monoclonal antibody targeting S100A4, a DAMP protein implicated in severe, life-threatening fibrotic diseases CAL101 being investigated in Phase 2 IPF Study; enrollment ongoing at sites in the USA, UK, EU, Turkey and South Korea OSLO, Norway & BOSTON–(BUSINESS WIRE)–Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat … [Read more…]
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, today announced the pricing of an underwritten public offering of 13,700,000 shares of its common stock at a price to the public of $18.25 per share. Gross … [Read more…]
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line treatment in patients with unresectable, locally advanced or metastatic HER2 overexpressing and PD-L1 TPS <50% non-squamous non-small cell lung cancer (NSCLC). ENHERTU is … [Read more…]
New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA Workflow on EZ2 Connect Fx delivers high-quality DNA in under 2.5 hours, minimizing hands-on time and variability with current manual process QIAGEN to showcase new kit and forensics portfolio at upcoming ISHI 2025 meeting GERMANTOWN, … [Read more…]
